-
Colombian police capture wife, daughter of Ecuador drug lord
-
Comedian on trial for allegedly insulting Erdogan in standup show
-
More Asian Games woes as bus takes Pakistan team to wrong venue
-
More Asian Games transport woes as bus takes Pakistan to wrong venue
-
Radio frequencies vital to Earth observation must be protected: UN
-
Death toll in South Africa bar shooting rises to 18
-
Comedian on trial for insulting Erdogan in standup show
-
Aide to Venezuelan opposition leader returns from exile
-
Women's Fashion Week kicks off in Paris
-
Messi and Alcaraz love it, now padel takes step closer to Olympics
-
Pope arrives in French border city to speak on united Europe
-
Tolls mount in Thailand, Myanmar floods
-
The wildfires choking Indonesia, sparking regional haze
-
Why India's opposition wants top poll official out
-
PU Prime Deepens Argentina Presence Through FX Expo Buenos Aires 2026
-
PU Prime Strengthens UAE Momentum with Strong Showing at Forex Expo Dubai 2026
-
Nothing to seal here: NZ police help stranded pup home
-
Eight dead in Thailand floods since mid-September
-
White House releases list of products US, China could tax less
-
Oil prices spike after Trump rejects Iran truce offer
-
'Pseudo-journalism': Partisan 'news' sites target US midterms
-
Taylor Swift sets new record at MTV VMAs
-
'Currently impossible': North Korea defections in freefall
-
Seoul seeks apology after Ukraine reveals transfer of North Korean POWs
-
Erasmus sizes up 'improved' Wallabies ahead of 2027 World Cup
-
Messi on target again but Miami downed by Columbus
-
Scandal-weary Brazilians to vote as Lula faces Bolsonaro son
-
In Washington's political cauldron, a fight over foie gras
-
SpaceX aims to put Starship in orbit for the first time
-
Flavio Bolsonaro: political heir in his father's shadow
-
Pope to speak on united Europe from French border town
-
Ravens grab last-second win in Rio as Commanders stop Seahawks
-
Fulcrum Metals PLC Announces Interim Results for the six months to 30 June 2026
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 28
-
Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report
-
Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
-
Eagle Plains' Partner Xcite Uranium Intersects Anomalous Radioactivity at Lorado and Commences Drill Program at the Gulch Uranium Project, Saskatchewan
-
Helio Launches Asia Investor and Customer Marketing Roadshow to Capture Surging Regional Demand for Commercial Space Exposure
-
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
-
Camino Receives Environmental Approval for Significant Exploration Expansion at the Costa de Cobre Copper Project in Peru
-
Scheffler makes sportsmanship stand over tee screamer
-
USA rallies to capture 11th consecutive Presidents Cup
-
Anthropic CEO Amodei to dine with Trump at White House
-
Phillies clinch, Astros wrap up division on final day of MLB season
-
Dupont scores twice to send Toulouse to Top 14 summit
-
Commanders hand champion Seahawks their first loss
-
Greece stun Klopp's Germany as Ireland show sorrow for Gaza
-
Dupont scores twice to send Toulouse top of Top 14
-
Ramos fires holders Portugal to Nations League win in Norway
-
Ireland beat Israel but no handshakes due to war in Gaza
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
R.Lee--AT